Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | MLYS | HRMY |
|---|---|---|
| Price | $23.30 | $39.92 |
| Change today | ▼ 1.40% | ▲ 0.71% |
| Market cap | $2.06B | $2.32B |
| Return, 3 months | -23.5% | +4.3% |
| Return, year to date | -35.8% | +6.7% |
| Return, 1 year | -38.7% | +50.1% |
| P/E (TTM) | -5.5 | 12.9 |
| P/B | 3.7 | 2.3 |
| P/E percentile vs own 5y | – | 41st |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | +13.0% | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +118.9% | +16.3% |
| Analyst buy share | 100% | 57% |
| RSI (14) | 34 | 47 |
| 30-day volatility | 67.5% | 27.4% |
| Max drawdown, 1 year | -52.5% | -34.5% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
